BackNovo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Goodwill

Novo Nordisk A/S Class B's goodwill is $20B.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$19.89B

Peer trimmed avg / median

Loading

Novo Nordisk A/S Class B Goodwill History

Loading

Novo Nordisk A/S Class B vs. peers: Goodwill Comparison

Loading

Novo Nordisk A/S Class B Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novo Nordisk A/S Class B (NONOF) FAQ

Novo Nordisk A/S Class B (NONOF) currently reports a goodwill of $20B as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Novo Nordisk A/S Class B's goodwill history and peer comparisons.

Novo Nordisk A/S Class B's goodwill changed from $0 to $20B (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novo Nordisk A/S Class B reported $20B in goodwill as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $20B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Novo Nordisk A/S Class B, and consider following NONOF for alerts when major investors trade the stock.

Novo Nordisk A/S Class B is classified in the Healthcare sector. On goodwill, it currently shows $20B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NONOF with unrelated industries.